Strides Pharma Science surges 11% on development of Favipiravir; claims drug effectiveness against COVID-19
Updated : April 29, 2020 10:17 AM IST
The stock rose as much as 8.4 percent to Rs 408 per share on BSE.
Favipiravir tablets have demonstrated positive outcomes in COVID-19 treatment globally.
Strides Pharma is the first Indian Company to have commenced the export of Favipiravir tablets.